Federal Register of Legislation - Australian Government

Primary content

PB 76 of 2022 Determinations/Health as made
This instrument amends the National Health (Originator Brand) Determination 2015 to determine originator brands of pharmaceutical items for two drugs new to the F2 formulary on 1 August 2022.
Administered by: Health and Aged Care
Registered 29 Jul 2022
Tabling HistoryDate
Tabled HR01-Aug-2022
Tabled Senate02-Aug-2022
To be repealed 23 Nov 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 76 of 2022

 

National Health (Originator Brand) Amendment Determination 2022 (No. 3)

 I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated               28 July 2022              

NIKOLAI TSYGANOV

Acting Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care


 

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments                                                                                           2

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)                            2

 

 


1  Name

                   This instrument is the National Health (Originator Brand) Amendment Determination 2022 (No. 3).

                   This instrument may also be cited as PB 76 of 2022.

2  Commencement

             (1)  Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

 1 August 2022

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 99ADB(6B) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

1  Schedule 1, (after table item 210)

Repeal the items:

211

Simvastatin

Lipex 10

Lipex 20

Lipex 40

Lipex 80

Zocor

 

 

211A

Somatropin

Genotropin

Genotropin GoQuick

Genotropin MiniQuick

Substitute:

211

Simvastatin

Lipex 10

Lipex 20

Lipex 40

Lipex 80

Zocor

 

 

211A

Sitagliptin

Januvia

 

 

211B

Sitagliptin with metformin

Janumet

Janumet XR

 

 

211C

Somatropin

Genotropin

Genotropin GoQuick

Genotropin MiniQuick